knowledge -WSS

knowledge

author：Wikipedia 2025-08-11 16:23:54 - browse：4

Moderna chairman Noubar Afeyan exuded star power earlier this month as he commanded the spotlight at BIO 2023, the industry’s largest convention.

Basking in the accolades heaped on Moderna’s celebrated Covid-19 vaccine, Afeyan regaled the Boston audience with the company’s origin story and greeted fans who lined up to snap selfies with him. Stuart Cable, a partner in the law firm Goodwin who’s represented Moderna and joined Afeyan on stage, called Moderna “arguably the most successful story in the history of biotechnology.”

But the Cambridge, Mass.-based company can’t afford to rest on its laurels. Two and a half years after its vaccine liberated tens of millions from pandemic lockdowns — ringing up more than $36 billion in sales so far — Moderna faces a changing business and regulatory environment. Demand for Covid shots is waning, a backlash over drug prices is gaining traction, and questions about its next act loom.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Anesthesiologist group: stop taking Ozempic before surgery
Next article： As AI regulations shape up, health tech startups beg for clarity

WSS

Key Senate committee drafts bipartisan bill to stem drug shortages

Readout Newsletter: Bayer, Rapt Therapeutics, Sanofi shortage

Why rehabilitation engineers need to center patients in their research

MultiPlan and major insurers sued for alleged medical price

Q&A: Jennifer Adair on making gene therapy available globally

Readout Newsletter: Bayer, Rapt Therapeutics, Sanofi shortage

focus

knowledge

hotspot

Dobbs anniversary: the lost opportunity of abortion as health care

In 'major milestone,' FDA approves first cell therapy for solid tumors

Medicare proposal to cover medical devices draws a mixed reaction

Melinda French Gates resigns from Gates Foundation

Medical records are filled with copy

New CMS data security rules will hurt Medicare, Medicaid research

Bright Health sells Medicare Advantage business to Molina

WATCH: Why do our ears pop?

Supreme Court strikes down use of affirmative action

Why rehabilitation engineers need to center patients in their research

hotspot

Why does health care cost so much? A reading guide

Secretariat’s lessons for human medicine

MultiPlan and major insurers sued for alleged medical price

H5N1 bird flu virus started spreading in cows in Texas in December

Bird flu in milk supply is likely coming from asymptomatic cows

Medicare Advantage enrollment hits roughly 33.4 million

focus

focus

knowledge

focus